Magnetic resonance imaging (MRI) plays a valuable role in many task related with characterization of prostate cancer lesions. Recently, the DCE-MRI (Dynamic contrast Enhanced) has allowed to visualize and localize potential tumor regions. Specifically, Ktrans, from DCR-MRI, has shown to be a powerful pharmacokinetic parameter that allows to characterize tumor biology and to detect treatment responses from reconstructed coefficient maps of capillary permeability. Nevertheless, even expert-based analysis of Ktrans sequences are subject to a large false positive findings (FPF). In much of such cases, the prostate angiogenesis, or benign prostatic hyperplasia (BPH) regions are misclassified as cancer findings. This work introduces a robust deep convolutional strategy that characterizes Ktrans regions and allows an automatic prediction of cancer findings. The proposed strategy was validated over the SPIE-AAPM-NCI PROSTATEx public dataset with 320 multimodal images on peripheral, transitional and anterior fibromuscular stroma regions. The best configuration of proposal strategy achieved an area under the ROC curve (AUC) of 0.74. Additionally, the proposed strategy achieved a proper characterization by using mainly Ktrans information that together with T2-MRI-transaxial overcome baseline strategies that use additional modalities of MRI.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.